Cortisol

Biomarker3 papers3 findings

  • Human trial1
  • Humans2

Associations

2

Atherosclerotic cardiovascular disease

upin humans1

1 study
  1. Cortisol predicts atherosclerotic cardiovascular disease in humans (AUC 0.820, 95% CI 0.781-0.860).

    Humansnonfunctioning adrenal adenomas with post-DST cortisol <= 1.8 ug/dL

    Association of Post-Dexamethasone Cortisol With Cardiovascular and Metabolic Comorbidities in Patients With Nonfunctioning Adrenal Adenomas · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 1 Oct 2026

  2. Cortisol is associated with atherosclerotic cardiovascular disease in humans (aOR 1.21, 95% CI 1.09-1.34).

    Humansnonfunctioning adrenal adenomas with post-DST cortisol <= 1.8 ug/dLper 0.1 ug/dL increase

    Association of Post-Dexamethasone Cortisol With Cardiovascular and Metabolic Comorbidities in Patients With Nonfunctioning Adrenal Adenomas · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 1 Oct 2026

Atherosclerotic cardiovascular disease →

Metabolic syndrome

upin humans1

1 study
  1. Cortisol is associated with metabolic syndrome in humans (aOR 1.24, 95% CI 1.13-1.35).

    Humansnonfunctioning adrenal adenomas with post-DST cortisol <= 1.8 ug/dLper 0.1 ug/dL increase

    Association of Post-Dexamethasone Cortisol With Cardiovascular and Metabolic Comorbidities in Patients With Nonfunctioning Adrenal Adenomas · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 1 Oct 2026

Metabolic syndrome →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 23